Iladatuzumab vedotin [1906205-77-3]

TargetMol Chemicals

Iladatuzumab vedotin [1906205-77-3]

16

Research Use Only

Monoclonal

Iladatuzumab vedotin (DCDS-0780A), an antibody-drug conjugate (ADC), is a fusion of a humanized IgG1 anti-human CD79B monoclonal antibody (MCDS0593A) and the cytotoxic agent MMAE, linked through a protease-labile linker. Utilizing novel THIOMAB technology (TDC), it achieves precise conjugation of two MMAE molecules per antibody via engineered cysteine residues. This compound holds promise for research in B-cell non-Hodgkin lymphoma (B-NHL) [1].

-20°C

12352203